bioMérieux S.A.

Informe acción ENXTPA:BIM

Capitalización de mercado: €11.5b

bioMérieux Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Pierre Boulud

Chief Executive Officer (CEO)

€2.5m

Compensación total

Porcentaje del salario del CEO25.7%
Permanencia del CEO1.3yrs
Participación del CEOn/a
Permanencia media de la dirección3.3yrs
Promedio de permanencia en la Junta Directiva10yrs

Actualizaciones recientes de la dirección

Recent updates

Is bioMérieux (EPA:BIM) Using Too Much Debt?

Nov 01
Is bioMérieux (EPA:BIM) Using Too Much Debt?

Is There An Opportunity With bioMérieux S.A.'s (EPA:BIM) 31% Undervaluation?

Oct 14
Is There An Opportunity With bioMérieux S.A.'s (EPA:BIM) 31% Undervaluation?

bioMérieux S.A.'s (EPA:BIM) Popularity With Investors Is Under Threat From Overpricing

Sep 26
bioMérieux S.A.'s (EPA:BIM) Popularity With Investors Is Under Threat From Overpricing

bioMérieux S.A. (EPA:BIM) Just Reported Interim Earnings: Have Analysts Changed Their Mind On The Stock?

Sep 08
bioMérieux S.A. (EPA:BIM) Just Reported Interim Earnings: Have Analysts Changed Their Mind On The Stock?

Return Trends At bioMérieux (EPA:BIM) Aren't Appealing

Aug 03
Return Trends At bioMérieux (EPA:BIM) Aren't Appealing

bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings

May 30
bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings

Investors Met With Slowing Returns on Capital At bioMérieux (EPA:BIM)

Apr 18
Investors Met With Slowing Returns on Capital At bioMérieux (EPA:BIM)

bioMérieux's (EPA:BIM) Conservative Accounting Might Explain Soft Earnings

Mar 31
bioMérieux's (EPA:BIM) Conservative Accounting Might Explain Soft Earnings

bioMérieux S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Mar 17
bioMérieux S.A. Just Missed Earnings - But Analysts Have Updated Their Models

These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

Mar 15
These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings

Jan 27
bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings

bioMérieux (EPA:BIM) Has More To Do To Multiply In Value Going Forward

Jan 06
bioMérieux (EPA:BIM) Has More To Do To Multiply In Value Going Forward

A Look At The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

Dec 16
A Look At The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

Oct 23
These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

bioMérieux (EPA:BIM) Has Some Way To Go To Become A Multi-Bagger

Oct 05
bioMérieux (EPA:BIM) Has Some Way To Go To Become A Multi-Bagger

There May Be Reason For Hope In bioMérieux's (EPA:BIM) Disappointing Earnings

Sep 15
There May Be Reason For Hope In bioMérieux's (EPA:BIM) Disappointing Earnings

Estimating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

Sep 07
Estimating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?

Jun 30
Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?

Returns At bioMérieux (EPA:BIM) Appear To Be Weighed Down

Jun 09
Returns At bioMérieux (EPA:BIM) Appear To Be Weighed Down

Is bioMérieux (EPA:BIM) Using Too Much Debt?

Mar 31
Is bioMérieux (EPA:BIM) Using Too Much Debt?

The Return Trends At bioMérieux (EPA:BIM) Look Promising

Feb 23
The Return Trends At bioMérieux (EPA:BIM) Look Promising

Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?

Jan 27
Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?

bioMérieux (EPA:BIM) Has A Pretty Healthy Balance Sheet

Dec 16
bioMérieux (EPA:BIM) Has A Pretty Healthy Balance Sheet

bioMérieux (EPA:BIM) Ticks All The Boxes When It Comes To Earnings Growth

Oct 18
bioMérieux (EPA:BIM) Ticks All The Boxes When It Comes To Earnings Growth

Is bioMérieux (EPA:BIM) Using Too Much Debt?

Sep 14
Is bioMérieux (EPA:BIM) Using Too Much Debt?

Investors Should Be Encouraged By bioMérieux's (EPA:BIM) Returns On Capital

Aug 11
Investors Should Be Encouraged By bioMérieux's (EPA:BIM) Returns On Capital

An Intrinsic Calculation For bioMérieux S.A. (EPA:BIM) Suggests It's 20% Undervalued

Jul 23
An Intrinsic Calculation For bioMérieux S.A. (EPA:BIM) Suggests It's 20% Undervalued

Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?

Jul 05
Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?

bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85

May 26
bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85

Shareholders Would Enjoy A Repeat Of bioMérieux's (EPA:BIM) Recent Growth In Returns

May 11
Shareholders Would Enjoy A Repeat Of bioMérieux's (EPA:BIM) Recent Growth In Returns

bioMérieux (EPA:BIM) Is Paying Out A Larger Dividend Than Last Year

Apr 23
bioMérieux (EPA:BIM) Is Paying Out A Larger Dividend Than Last Year

bioMérieux (EPA:BIM) Has Announced That It Will Be Increasing Its Dividend To €0.85

Apr 09
bioMérieux (EPA:BIM) Has Announced That It Will Be Increasing Its Dividend To €0.85

bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85

Mar 25
bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85

Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?

Mar 13
Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?

I Ran A Stock Scan For Earnings Growth And bioMérieux (EPA:BIM) Passed With Ease

Feb 08
I Ran A Stock Scan For Earnings Growth And bioMérieux (EPA:BIM) Passed With Ease

Why We Like The Returns At bioMérieux (EPA:BIM)

Dec 21
Why We Like The Returns At bioMérieux (EPA:BIM)

Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

Dec 07
Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

Here's Why We Think bioMérieux (EPA:BIM) Is Well Worth Watching

Nov 07
Here's Why We Think bioMérieux (EPA:BIM) Is Well Worth Watching

Is bioMérieux (EPA:BIM) A Risky Investment?

Oct 07
Is bioMérieux (EPA:BIM) A Risky Investment?

Investors Shouldn't Overlook bioMérieux's (EPA:BIM) Impressive Returns On Capital

Sep 22
Investors Shouldn't Overlook bioMérieux's (EPA:BIM) Impressive Returns On Capital

Estimating The Fair Value Of bioMérieux S.A. (EPA:BIM)

Sep 07
Estimating The Fair Value Of bioMérieux S.A. (EPA:BIM)

Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today

Aug 06
Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today

There's Been No Shortage Of Growth Recently For bioMérieux's (EPA:BIM) Returns On Capital

Jun 15
There's Been No Shortage Of Growth Recently For bioMérieux's (EPA:BIM) Returns On Capital

A Look At The Fair Value Of bioMérieux S.A. (EPA:BIM)

May 31
A Look At The Fair Value Of bioMérieux S.A. (EPA:BIM)

Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today

Apr 30
Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today

bioMérieux (EPA:BIM) Could Easily Take On More Debt

Mar 28
bioMérieux (EPA:BIM) Could Easily Take On More Debt

The Trend Of High Returns At bioMérieux (EPA:BIM) Has Us Very Interested

Mar 13
The Trend Of High Returns At bioMérieux (EPA:BIM) Has Us Very Interested

Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

Feb 25
Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

If You Had Bought bioMérieux (EPA:BIM) Shares Five Years Ago You'd Have Earned 237% Returns

Feb 09
If You Had Bought bioMérieux (EPA:BIM) Shares Five Years Ago You'd Have Earned 237% Returns

If You Like EPS Growth Then Check Out bioMérieux (EPA:BIM) Before It's Too Late

Jan 20
If You Like EPS Growth Then Check Out bioMérieux (EPA:BIM) Before It's Too Late

Could The Market Be Wrong About bioMérieux S.A. (EPA:BIM) Given Its Attractive Financial Prospects?

Dec 30
Could The Market Be Wrong About bioMérieux S.A. (EPA:BIM) Given Its Attractive Financial Prospects?

These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

Dec 17
These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Pierre Boulud en comparación con los beneficios de bioMérieux?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2024n/an/a

€411m

Mar 31 2024n/an/a

€384m

Dec 31 2023€2m€631k

€358m

Sep 30 2023n/an/a

€372m

Jun 30 2023n/an/a

€386m

Mar 31 2023n/an/a

€419m

Dec 31 2022€2m€510k

€452m

Sep 30 2022n/an/a

€502m

Jun 30 2022n/an/a

€552m

Mar 31 2022n/an/a

€577m

Dec 31 2021€2m€510k

€601m

Sep 30 2021n/an/a

€555m

Jun 30 2021n/an/a

€509m

Mar 31 2021n/an/a

€457m

Dec 31 2020€1m€497k

€404m

Compensación vs. Mercado: La compensación total de Pierre($USD2.58M) está por debajo de la media de empresas de tamaño similar en el mercado French ($USD4.64M).

Compensación vs. Ingresos: La compensación de Pierre ha aumentado más de un 20% en el último año.

CEO

Pierre Boulud (53 yo)

1.3yrs

Permanencia

€2,452,864

Compensación

Mr. Pierre Boulud is Chief Executive Officer of bioMérieux S.A. from July 01, 2023. He served as Chief Operating Officer of Clinical Operations at BioMérieux S.A. until 2023 and served as its Chief Operati...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Pierre Boulud
Chief Executive Officer1.3yrs€2.45msin datos
Guillaume Bouhours
Executive VP of Purchasing and Information Systems & CFO6.7yrssin datossin datos
Sylvain Morgeau
Investor Relationsno datasin datossin datos
Audrey Dauvet
Executive Vice President of Legal1.8yrssin datossin datos
Valerie Leylde
Executive Vice President of Human Resources5.8yrssin datossin datos
Pierre Charbonnier
Executive Vice President of Global Quality6.7yrssin datossin datos
Yasha Mitrotti
Executive Vice President of Industrial Applications6.7yrssin datossin datos
Frederic Beseme
Head of CSR4.8yrs€21.99ksin datos
Jennifer Zinn
Executive Vice President of Clinical Operations1.3yrssin datossin datos
Charles Cooper
Executive VP & Chief Medical Officerless than a yearsin datossin datos
Celine Roger-Dalbert
Executive Vice President of Research & Developmentless than a yearsin datossin datos
Franck Admant
Director of Investor Relationsno datasin datossin datos

3.3yrs

Permanencia media

51.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de BIM se considera experimentado (3.3 años antigüedad media).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Alain Merieux
Founding Chairman7.3yrssin datossin datos
Jean-Luc Belingard
Non-Independent Director18.2yrs€52.00k0.051%
€ 5.9m
Philippe Archinard
Non-Independent Director14.4yrs€61.00k0.000030%
€ 3.5k
Alexandre Merieux
Chairman20.6yrs€1.92m0.000050%
€ 5.8k
Harold Y. Boel
Independent Director12.5yrs€56.00k0.00013%
€ 15.0k
Marie-Helene Habert-Dassault
Independent Director12.5yrs€44.00k0.000050%
€ 5.8k
Fanny Letier
Independent Director7.5yrs€61.17k0.000030%
€ 3.5k
Viviane Monges
Independent Directorless than a yearsin datossin datos
Marie-Paule Kieny
Independent Director7.3yrs€35.00k0.00015%
€ 17.3k
Sylvain Orenga
Employee Representative Director2.5yrs€52.00ksin datos

10.0yrs

Permanencia media

60.5yo

Promedio de edad

Junta con experiencia: Los miembros de la junta directiva de BIM son experimentados ( 10 años antigüedad media).